Necrosis: Research Studies

2 Related Result(s)

  1. Atezolizumab in Treating Patients With Recurrent BCG-Unresponsive Non-muscle Invasive Bladder Cancer

    This phase II trial studies how well atezolizumab works in treating patients with non-muscle invasive bladder cancer that has come back and has not responded...

  2. (ASLeap) Study Estimating the Clinical Difference Between 300 mg and 150 mg of Secukinumab Following Dose Escalation to 300 mg in Patients With Ankylosing Spondylitis

    Escalating the dose of Cosentyx is currently one approach for treating certain rheumatologic conditions. The purpose of this study is to discover if it is...